MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Apr 8, 2024 |
8 |
-$633K |
4 |
Apr 10, 2024 |
Pres., R&D, and CMO, Director |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Apr 3, 2024 |
25 |
-$17.3M |
4 |
Apr 5, 2024 |
Pres., R&D, and CMO, Director |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Jan 23, 2024 |
3 |
$0 |
4 |
Jan 25, 2024 |
Pres., R&D, and CMO, Director |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Jan 16, 2024 |
1 |
-$377K |
4 |
Jan 18, 2024 |
Pres., R&D, and CMO, Director |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Jan 16, 2023 |
1 |
$0 |
4 |
Jan 18, 2023 |
Pres., R&D, and CMO, Director |
BCTX |
BriaCell Therapeutics Corp. |
Aug 1, 2022 |
0 |
$0 |
3 |
Aug 1, 2022 |
Director |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Feb 22, 2022 |
1 |
$0 |
4 |
Feb 24, 2022 |
Chief Medical Officer, President, R&D ** As attorney-in-fact for Reporting Person, Director |